Speaker 1: This is Bloomberg Business Week. I'm Carol Masser. Every day
Speaker 1: we're bringing you the latest news from the world of
Speaker 1: business and finance, plus technology, politics. So much going on
Speaker 1: in the world of politics, economics, and it's all harnessing
Speaker 1: the power of Business Week reporters and editors. If you
Speaker 1: can download Bloomberg Business Week on iTunes, SoundCloud, or Bloomberg
Speaker 1: dot com. If you can also listen to our radio
Speaker 1: show at two pm Eastern on Bloomberg Radio, and be
Speaker 1: sure to watch us too on YouTube by searching Bloomberg
Speaker 1: Global News. J and Jay. Is highly anticipated single dose
Speaker 1: Kevin nineteen vaccine may not be authorized for use until March.
Speaker 1: That's weeks later than US officials have suggested. No. But
Speaker 1: you know, as every day goes by, you're so good
Speaker 1: at like counting the numbers of the deaths that we
Speaker 1: see and people who come down with it, so you know,
Speaker 1: simple math that could be you know what I mean,
Speaker 1: Like every day that goes by, I'm not trying to know.
Speaker 1: I mean, look, it's important we do the bite of
Speaker 1: the day here on the radio and on on Quick Take.
Speaker 1: We do by the numbers, and the number today was
Speaker 1: you know over it's a number of deaths yesterday. It's
Speaker 1: pretty it's pretty remarkable. It's pretty remarkable. And if we
Speaker 1: take a look at numbers right now, we've got cases
Speaker 1: of COVID nineteen topping now. Million deaths are passing one
Speaker 1: point nineties six million. That's a global number, and the
Speaker 1: vaccine tracker more than thirty point five million shots have
Speaker 1: been given worldwide. Lots going on. Let's see what our
Speaker 1: guest has to say about all of this. Dr Kirk
Speaker 1: Garrett is medical director of the Center for Heart and
Speaker 1: Vascular Health at the Christiana Care Health System. He spent
Speaker 1: seventeen years at the Mayo Clinic clinic excuse me, and
Speaker 1: was a member of the team of physicians who first
Speaker 1: performed minimally invasive heart procedures there. He joined this on
Speaker 1: the phone from Wilmington, Delaware. Dr Garrett, nice to have
Speaker 1: you here with Tim and myself. How are you and
Speaker 1: what are you seeing when it comes to COVID nineteen
Speaker 1: and your patients? Well, thanks for having me with you today.
Speaker 1: It's a pleasure. Of course. We're all struggling here to
Speaker 1: stay ahead of this. And the good news is I
Speaker 1: think that we're in most communities we're getting to a
Speaker 1: place where the peak of this resurgence period is coming
Speaker 1: into focus now as we start to roll out vaccines.
Speaker 1: As you were just discussing, we're optimistic that we're going
Speaker 1: to get control of this, but of course we have
Speaker 1: many weeks, probably many months ahead of us to still
Speaker 1: manage this disease. What do you mean when you say
Speaker 1: many weeks, many months? I mean are we talking like, um,
Speaker 1: return to normalcy at the end of the summer or
Speaker 1: we am I going to be able to see my
Speaker 1: parents at the beginning of the summer. What's going on here? Yeah,
Speaker 1: you know, at this point, really it's anybody's guests, you know.
Speaker 1: But what we do have as a pledge from government officials,
Speaker 1: both the current administration and the incoming administration to accelerate
Speaker 1: the rollout of the current stock of vaccinations, and that's
Speaker 1: very good news. Of course, we have to assure that
Speaker 1: we reserve enough to be sure everybody gets not one,
Speaker 1: but two injections. And then importantly, we have to continue
Speaker 1: production so that we as we use up the supply currently,
Speaker 1: that we can replace it at the rate that's needed. Right,
Speaker 1: government that we were going to do that, yeah, well,
Speaker 1: you know, the US government now wanting to offer vaccines
Speaker 1: to millions more Americans, and so we're talking about reducing
Speaker 1: the age and opening it up. We're now clearing a
Speaker 1: path for about twenty eight million more Americans to be vaccinated.
Speaker 1: Sounds good, right, opening it up. But at the same time,
Speaker 1: I think now we're like, wait a minute, do we
Speaker 1: have enough supply there? What are you hearing on that front? Well,
Speaker 1: I think we're hearing the same thing you are. We
Speaker 1: don't have any special conduit into the government administrative leaders here,
Speaker 1: and they're really the ones who are in charge. I
Speaker 1: think the War Production Act is is obviously a very
Speaker 1: important lever that's at the dispose of the administration to
Speaker 1: see to it that we can keep up production is needed.
Speaker 1: And we're all hoping that that happens quickly, but it
Speaker 1: hasn't so far. Yeah, Yeah, And I think that's been
Speaker 1: I think it's been a real challenge for for Americans.
Speaker 1: I mean, I know from my own perspective, just trying
Speaker 1: to think about what a realistic timeline here is for
Speaker 1: widespread vaccination. Here we are in January, it's been almost
Speaker 1: a year since this pandemic has absolutely changed the way
Speaker 1: that we live and change the way that we work
Speaker 1: and change the way that we travel, and we still
Speaker 1: don't know when we are going to see widespread inoculation.
Speaker 1: And I think it's just I think it's difficult for Americans.
Speaker 1: I mean, we asked, we have this conversation every day.
Speaker 1: We asked questions like what can we do to stop
Speaker 1: the spread until we get vaccinated? And you know, we
Speaker 1: hear the same thing over and over again, but it's
Speaker 1: it's not working, because yesterday was another record for deaths. Yeah,
Speaker 1: and you know, um, one of the parts of the
Speaker 1: conversation that I think hasn't gotten enough attention is that
Speaker 1: we we talk about the the excess mortality that's occurred
Speaker 1: in twenty as a result of this COVID nineteen pandemic.
Speaker 1: And typically what we're doing was recounting up the number
Speaker 1: of people we know to have died as a direct
Speaker 1: result of being infected. And that's tragic, and the number
Speaker 1: as huge, as you know, over the three hundred thousand
Speaker 1: estimate that was made early in we exceeded that. And
Speaker 1: you have the part of the conversation that I don't
Speaker 1: think we focused on those deaths that we know to
Speaker 1: be to have occurred in excess of expectations, but which
Speaker 1: are not attributable directly to a COVID nineteen infection. Well, well,
Speaker 1: why would that happen? Well has happened because COVID nineteen,
Speaker 1: in addition to making a whole lot of people very sick,
Speaker 1: has disrupted the usual provision of care for people with
Speaker 1: chronic conditions, and that's allowed them to decline and deteriorate
Speaker 1: and in some cases die. The Society for Cardiovascular Angiography
Speaker 1: and Intervention that I work with closely conducted a survey
Speaker 1: in March of twenty and found that an alarming percentage
Speaker 1: of people he said that even if they thought they
Speaker 1: were having a stroke or a heart attack, they would
Speaker 1: not go to a hospital because they were so afraid. Well, that,
Speaker 1: obviously is is a very dangerous proposition, and indeed we
Speaker 1: now know that many people did die as a consequence
Speaker 1: of delay of care. We repeated a survey in December
Speaker 1: and found that there have been improvements and fewer people
Speaker 1: are saying that they would be quite as reluctant, but
Speaker 1: still one in four Americans say they're still so afraid
Speaker 1: of COVID nineteen they won't even see their regular doctor
Speaker 1: in a regular doctor's appointment, and if you look at
Speaker 1: respondents who are African American or Latino, that number jumps
Speaker 1: to So we clearly have a lot of work yet
Speaker 1: to do to convince Americans that it's safe to remain
Speaker 1: engaged in routine healthcare, which we know is the key
Speaker 1: to surviving heart and basket or disease. Dr Garrett, One
Speaker 1: thing that I'm curious about is the financial strain that
Speaker 1: the COVID nineteen pandemic has had on healthcare systems. What
Speaker 1: are the changes that you've had to make at the
Speaker 1: Center for Heart and Vascular Health that the Christianity Care
Speaker 1: health System because of the different ways that you guys
Speaker 1: are prioritizing care. Well, you know, of course, it was
Speaker 1: it was a very substantial financial blow for healthcare systems
Speaker 1: across America when the when the pandemic broke out, and
Speaker 1: that was in large measure because the United States health
Speaker 1: system had to respond what it saw happening in places
Speaker 1: like New York City, which became quickly overrun with COVID
Speaker 1: nineteen victims. In order to prepare for that in every
Speaker 1: community in America, then hospitals went about emptying out their hospitals.
Speaker 1: They stopped doing usual work, no more hip replacements, no
Speaker 1: more elective persus. Is that the right thing to do
Speaker 1: at the time, Yes, I think at that moment it
Speaker 1: was absolutely the right thing to do, because no one
Speaker 1: knew what was coming, so we had to prepare for
Speaker 1: the worst case scenario, and we did. Now. Happily, most
Speaker 1: communities didn't suffer to the degree that New York City did,
Speaker 1: and we learned then through the spring and summer that
Speaker 1: indeed we didn't have to empty out all the beds.
Speaker 1: We could continue to provide normal services, just to care
Speaker 1: for neighbors in our communities and deliver the care that
Speaker 1: they needed, while also taking care of all the COVID
Speaker 1: nineteen patients. So we've we've learned those lessons, and at
Speaker 1: Christianitic Care, like other health systems, we've now remodeled our
Speaker 1: care delivery plan to accommodate both a large number of
Speaker 1: COVID nineteen patients and also be able to sustain care
Speaker 1: delivery for patient patients in need of other services. So
Speaker 1: how do you do that safely? Well, you know, it's
Speaker 1: actually not as hard as you might imagine. You've got
Speaker 1: to remember health care has been in the business of
Speaker 1: taking care of people around infectious diseases for hundreds of years.
Speaker 1: We know how to do this safely. Of course, when
Speaker 1: you have a brand new novel infectious agent like COVID
Speaker 1: nineteen breakthrough and you don't know how overwhelmed you might be,
Speaker 1: you pull out all the stops to prepare for the worst.
Speaker 1: Is mentioned. But now we understand what the magnitude of
Speaker 1: the of the resurgence is likely to be for us
Speaker 1: in our community, and we of course understand what safeguards
Speaker 1: need to be in place to take care of COVID
Speaker 1: and non COVID patients. Not quite side by side, that's
Speaker 1: a bit of hyperbole, but in the same setting, in
Speaker 1: the same building, sometimes even on the same hospital floors,
Speaker 1: and we can do that safely, and we are doing
Speaker 1: that safely. So there's obviously the health of your patients
Speaker 1: COVID and non COVID that you guys are certainly focused
Speaker 1: on at this point. There's also the health of you know,
Speaker 1: your institution. And Bloomberg has done so much reporting. Back
Speaker 1: in April we had stories about hospitals racing to secure
Speaker 1: big credit lifelines from Wall Street. And we're not talking
Speaker 1: about two smaller institutions, but like New York Presbyterian Hospital. Financially,
Speaker 1: there's been some strains too because people aren't doing those
Speaker 1: you know, kind of routine procedures. How strained are you
Speaker 1: guys feel feeling financially? And I know you can't speak
Speaker 1: for the hospital overall, but you are director of your
Speaker 1: particular area and probably see a lot of what's happening
Speaker 1: or not happening and the strains as a result. Sure,
Speaker 1: and I think it's fair to say that Heart and
Speaker 1: Basket Or services and healthcare system are an important component
Speaker 1: to the vitality of the organization. Uh And I will
Speaker 1: say that at the onset of this pandemic, we have
Speaker 1: christianit Care here. I emptied out every impatient bed that
Speaker 1: I had for heart vascular care in order to be
Speaker 1: ready to take care of an overwhelming pandemic. And it
Speaker 1: was the right thing to do. It came with financial consequences,
Speaker 1: but we prepared, We were prepared to face that. Now,
Speaker 1: of course, we don't have to do that. And although
Speaker 1: one of four floors dedicated to Heart and Basket or
Speaker 1: Care is still fully dedicated to COVID care, currently one
Speaker 1: one of four Heart and BASKETAR floors and the service
Speaker 1: as a usual man. Not where we were last year,
Speaker 1: and certainly not where we would like to be. But
Speaker 1: we're more important even than the financial balance of this.
Speaker 1: We want to be sure that we're providing the services
Speaker 1: that are needed by our community and and that we
Speaker 1: feel we were able to meet today. Um. Dr Garrett,
Speaker 1: have you I just want to end with this. We
Speaker 1: don't have much time. Have you taken the vaccine yet? Yes?
Speaker 1: I happily got my first shot about a week and
Speaker 1: a half ago, and I can't wait to get the next.
Speaker 1: All right, there it is. I can't wait either first, Yeah,
Speaker 1: exactly right. Sooner, sooner, hope hopefully rather than later. Dr
Speaker 1: Kirk Garrett, thank you so much, Medical director of the
Speaker 1: Center for Heart and Vascular Health at the Christiana Care
Speaker 1: Health System. Joining us on the phone from Wilmington, Delaware.
Speaker 1: This is Bloomberg Business Week with Carol Messer from Bloomberg Radio. Well,
Speaker 1: this week's cover story is about the love affair between
Speaker 1: Elon Muskin China. So far, so good, and yet time
Speaker 1: we'd how longer term? Let's hear more though with Bloomberg
Speaker 1: Business Week Features editor Max Chaffin. He's one of the
Speaker 1: editors on this story. He's on the phone, and Queen's
Speaker 1: along with Bloomberg Business. We getittor Joe Webber on the
Speaker 1: access line in Brooklyn. I should point out several reporters
Speaker 1: contributing to this story, including Hayes Fan who's a member
Speaker 1: of Bloomberg News is Beijing Bureau, who contributed before being
Speaker 1: detained by Chinese authorities in December. So we did want
Speaker 1: to put that out there. Um, it's an important story,
Speaker 1: and I feel like that note in terms of our
Speaker 1: reporters just reminds us of kind of the love affair
Speaker 1: and the conflict that we kind of have with China
Speaker 1: constantly here, including potentially maybe Joel Ellen Musk and Tesla
Speaker 1: going forward. Yeah, and the story is a real repeating,
Speaker 1: a real reporting um feat and the story is ultimately
Speaker 1: about how Tesla um and trying to find themselves in
Speaker 1: this little love affair. And UM hence why our cover
Speaker 1: line is China's favorite Capitalist and that refers to Elon
Speaker 1: Musk and China has really given Tesla just an amazing
Speaker 1: amount of autonomy that most Western companies don't enjoy um
Speaker 1: when they do business in China, and it's been rewarded
Speaker 1: um by being able to have this autonomy, and Tesla's
Speaker 1: behaved basically by by having its own Tesla, Chinese operation
Speaker 1: basically become almost autonomous within UM within Tesla itself. UM.
Speaker 1: But you know what what this really comes down to
Speaker 1: is you know what's in it for China here? And
Speaker 1: bring Max in on that note. You know, one of
Speaker 1: the things that China has been able to accomplish here
Speaker 1: is to almost use Tesla as uh, you know, like
Speaker 1: almost like a whipping agent that it can kind of
Speaker 1: kick the rest of it's ev aspirations into ligne with Max.
Speaker 1: What what is is the in game? Um, both for
Speaker 1: for Elon and for China. Do you think so? On
Speaker 1: the China side, Uh, there are there are a few things.
Speaker 1: So so one, as you said, uh, Chinese government is
Speaker 1: very committed to electric vehicles. So so that means that
Speaker 1: you know, there are a zillion sort of incentive for
Speaker 1: purchases of electric cars as well as sort of disincentives,
Speaker 1: taxes and that sort of thing on those who want
Speaker 1: to purchase um uh, you know, conventional vehicles, gas power vehicles.
Speaker 1: So so China's got this idea, you know, this is
Speaker 1: part of it. The sort of grand plan is is
Speaker 1: to create this gigantic um electric car industry, and you know,
Speaker 1: from the sort of Chinese economic policy makeup point of view,
Speaker 1: having Tesla in the country, especially and especially having a
Speaker 1: test of factory in the country, and that's that's one
Speaker 1: of the ways in which they really helped Tesla, you know,
Speaker 1: is a boon to to China because um, you know,
Speaker 1: it's it's not just the factory, it's the supply chain.
Speaker 1: So on one hand, like Tesla rings added competition, maybe
Speaker 1: that gives a sort of kick to the other Chinese
Speaker 1: electric fart makers, but it also creates this supply chain
Speaker 1: where you have the people who supply batteries and people
Speaker 1: whose supply breaks you know, uh, software whatever, like, all
Speaker 1: of that gets set into this this factory in China,
Speaker 1: and that helps the local economy. Um. You know. On
Speaker 1: the Tesla side, it's kind of the same thing, which
Speaker 1: is that this is a big uh, this is a
Speaker 1: growth market. It's it's arguably, um, you know, the most
Speaker 1: important electric vehicle market. It's it's where right now at
Speaker 1: least you know, Tesla's growth is going to come from.
Speaker 1: And uh, what sort of makes this interesting is that
Speaker 1: you know, Elon Musk has been able It's a really
Speaker 1: underappreciated part of about Elon Musk is that he's he's
Speaker 1: very good at politics. Um, you know, at a time
Speaker 1: when you know there's been this trade war, when when
Speaker 1: lots of other companies have have struggled with China, he's
Speaker 1: been able to kind of figure out a way to
Speaker 1: work it so that he's able to to open this factory,
Speaker 1: make Beijing happy, uh, and sort of do do a
Speaker 1: lot of business. That The risk, of course, is that
Speaker 1: really at any time, you know that the scales could
Speaker 1: change and China could create additional restrictions or do all
Speaker 1: sorts of stuff that would make Tesla's life not so great.
Speaker 1: Could do other companies? Can other companies learn from what
Speaker 1: Elon Musk has has done in China? How Elon Musk
Speaker 1: has been able to succeed in a place where so
Speaker 1: many American companies haven't been able to because they have
Speaker 1: to be so jealous Max, because it's been so hard
Speaker 1: for everybody else, and it's taken a long time to
Speaker 1: kind of get any kind of foothold there. Yeah, I
Speaker 1: mean I think that you know, Tesla had certain things
Speaker 1: going for it that that Elon was able to take
Speaker 1: advantage of And I don't know that this is I'm
Speaker 1: not sure there's a sort of like a how to
Speaker 1: lesson here, to be honest, because um Joel kind of
Speaker 1: hinted at this, But having Elon Musk open a factory
Speaker 1: in China has not just economic value to UH, to Beijing,
Speaker 1: it has kind of propaganda value, you know, at a
Speaker 1: time when you know, when sort of American companies are
Speaker 1: dealing with you know, lots of hostility. When when when
Speaker 1: there's this trade war going on with Trump, um Elon
Speaker 1: Musk is able to sort of figure that out right.
Speaker 1: He was able to ask for more than pretty much
Speaker 1: anyone could ask for, and he got something that no
Speaker 1: other car company had gotten, you know to date, which
Speaker 1: is trying to change the rules on sort of foreign
Speaker 1: ownership UH and and Tesla use that to allow to
Speaker 1: to have a hundred percent ownership of its of its
Speaker 1: joint venture. So I don't think this is a case
Speaker 1: of of of must doing something that you know, other
Speaker 1: companies could could could emulate. It's it's more a case
Speaker 1: of Musk having things that China wanted. Yeah, I think
Speaker 1: that's just to underscore that, you know, no other foreign
Speaker 1: company has ever been able to have UM that deal
Speaker 1: struck that Elon got that you know, instead of having
Speaker 1: a joint venture, which is usually you know, a Chinese
Speaker 1: owned company will have to have a stake in whatever
Speaker 1: that factory was, Ellen got something that the Chinese have
Speaker 1: never given anyone else, which is he got to own
Speaker 1: that that and with that came even more floods of
Speaker 1: Chinese backing. So it really was, you know, a subsidized venture.
Speaker 1: And that is something that back to this point, I
Speaker 1: don't know if you can really have UM any more
Speaker 1: how to lessons than that. And it was because I think,
Speaker 1: to give you a number here, like at one point,
Speaker 1: China has had as many as five electric vehicle startups.
Speaker 1: And when you bring in a car manufacturer like Tesla
Speaker 1: that has that Western appeal, it allows you to start
Speaker 1: having a switch to basically say we can like really
Speaker 1: bring our our e V domestic e V manufacturers into line.
Speaker 1: Here and Max, I guess that's the thing I just
Speaker 1: wanted to bring it back to you to as we
Speaker 1: wrap here, is you know, it does incentivize UM. China
Speaker 1: needs manufacturers to get their stuff together. So what what
Speaker 1: does that competition end up looking like? Potentially for Tesla
Speaker 1: and Max just got about twenty five seconds. Yeah, so
Speaker 1: it's going to be tight. There are lots of companies
Speaker 1: there and um and they're making products that are are
Speaker 1: good and that are competitive and in some case cheaper
Speaker 1: than Tesla's. The thing is, you know, none of them
Speaker 1: have that Tesla luster. I mean, this is a brand
Speaker 1: like Apple and that you know is going to mean
Speaker 1: a lot to consumers all over the world, including in China. Well,
Speaker 1: I love the last line in the story of Shanghai
Speaker 1: based consultant said Tesla got all of this because it
Speaker 1: was in China's interest for Tesla to have it. It's
Speaker 1: a great story. Deep deep, deep dive. Alright, guys, thank
Speaker 1: you so much. Joe Weber, editor of Bloomberg Business Week,
Speaker 1: Max Chafkin, one of the editors on this story, over
Speaker 1: Bloomberg Business Week, joining us on the phone. This is
Speaker 1: Bloomberg Business Week with Carol Messer from Bloomberg Radio. Headline
Speaker 1: crossing uh, US Senate Majority Leader at MS McConnell saying
Speaker 1: uh that he's he's telling the GPS no, no decision
Speaker 1: has been made on how he will vote. He actually
Speaker 1: put out a statement him. Yeah, his statement says, well,
Speaker 1: the press has been full of speculation. I have not
Speaker 1: made a final decision on how it will vote, and
Speaker 1: I intend to listen to the legal arguments when they
Speaker 1: are presented to the Senate. But Carol, I think it's
Speaker 1: notable that McConnell's not coming out right now and saying no, no, yeah, exactly.
Speaker 1: That's a big deal. It is a big deal. And
Speaker 1: we heard that from our own team to weighing in
Speaker 1: who covers the White House? Uh, this whole idea that
Speaker 1: you know, that's a big deal. That what we got
Speaker 1: from McConnell last night the New York Times reporting on it.
Speaker 1: It is a big deal as the House votes on
Speaker 1: impeachment at issue. Though ultimately Tim and you and I've
Speaker 1: talked about this a lot. Are President Trump's actions and words,
Speaker 1: in particular those in the social media world. There's a
Speaker 1: company that tracks toxicity on social media. Mayhabib is the
Speaker 1: co founder and CEO of Writer. It's an AI and
Speaker 1: n LP, which I now know stands for neuro Linguistic
Speaker 1: Programming Company learned something every day. She joins us on
Speaker 1: the phone in San Francisco, where the company's based. May
Speaker 1: so good to have you with Tim and myself just
Speaker 1: quickly briefly for our audience, exactly what you guys are
Speaker 1: doing on a regular basis. Good morning Carol. Um. It's
Speaker 1: actually natural language processing the other n LP. But we
Speaker 1: are an AI writing assistant, so we help correct language
Speaker 1: and in addition to stylistic and grammar type corrections, UM,
Speaker 1: we will also correct on what we call healthy communication,
Speaker 1: and that's a lot of you know, uh, stripping out passive,
Speaker 1: aggressive language and toxic language, mainly for a a workplace
Speaker 1: use case. So if our company has got a website
Speaker 1: right and is doing things that, that's what you're that's
Speaker 1: what you're going through. You're making sure that their message
Speaker 1: comes across in a non toxic way. Yes, in addition
Speaker 1: to emails, they may find their customers or chats in
Speaker 1: between colleagues. But we basically kind of pointed this very
Speaker 1: powerful technology at the Twitter stream to some interesting results. Yeah.
Speaker 1: And one thing that it's really fascinating about this is
Speaker 1: you've been analyzing tweets since the election this fall, including
Speaker 1: the tweets from President Trump, from President Obama, and from
Speaker 1: President elect Joe Biden. And I was surprised to see
Speaker 1: UM that Obama's tweets even though they have been relatively muted,
Speaker 1: they've come out strongly against the events on Capitol Hill.
Speaker 1: You said that of his tweets last Friday were classified
Speaker 1: as toxic between compared to as a daily average of
Speaker 1: less than ten percent. I was surprised to see that
Speaker 1: because I don't I don't wouldn't think of the President
Speaker 1: Obama's tweets as toxic. Explain, yeah, absolutely, I mean what
Speaker 1: we tried to build was a data set where UM,
Speaker 1: inflammatory language on both sides of a debate is flagged,
Speaker 1: and you know, aggressive posturing, aggressive language is what gets
Speaker 1: UH flagged. And uh, you know, President Obama was absolutely
Speaker 1: very forceful in his condemnation and that's what we picked
Speaker 1: up on UM. And uh, you know, even even if
Speaker 1: you compare it to the ways in which uh Biden
Speaker 1: condemned UM, there was you know, different different words chosen. UM. Now,
Speaker 1: of course that makes sense politically, right. One is a
Speaker 1: former president, one is an incoming president UM for whom
Speaker 1: UM uniting both sides of the country is something that
Speaker 1: he's wanted to do. But and both are in stark
Speaker 1: contrast to the language that you know Trump is a regular.
Speaker 1: But I want to ask you about that. But what
Speaker 1: makes something toxic? Is it using caps? Is it using
Speaker 1: exclamation points? What you know makes something toxic? It's absolutely
Speaker 1: all of the above, Carol, So are models taken to account?
Speaker 1: Punctuation addictions since taps UM? And then the actual words,
Speaker 1: so UM, you know, stolen if it is in all caps,
Speaker 1: riggs regardless of how you write it, fite regardless of
Speaker 1: how you write it. UM. And then things that are
Speaker 1: you know, verifiably UM, untrue UM you know, are also
Speaker 1: part of UM like a fly business toxic. So what
Speaker 1: do you find when you tracted our you know, tracked
Speaker 1: what President Trump has put out there? So there were
Speaker 1: there were some interesting findings. The first overall, on January six,
Speaker 1: all of Twitter was quite toxic UM. So thirty two
Speaker 1: percent of all of twitter UM was contained inflammatory of
Speaker 1: all tweets contains inflammatory UM language. It was really interesting.
Speaker 1: Is Trump's contribution to that? I remember he had eighty
Speaker 1: eight million followers, and and beyond just kind of his
Speaker 1: immediate reach, things were ample. Things that Trump tweeted were
Speaker 1: amplified by virtue of just the degree to which he
Speaker 1: gets liked in and retweeted UM, and so by by
Speaker 1: virtual Those eight million followers. What we found, um was
Speaker 1: language amplified by him, which includes you know, steal, the steal,
Speaker 1: the word fight, the word rigged, Um, we're actually president,
Speaker 1: and almost half of all toxic tweets on the six
Speaker 1: across the entire Twitter stream, um, which is which is
Speaker 1: really astounding. I mean, you know, there are a lot
Speaker 1: of ways that people are looking at his band from
Speaker 1: Twitter and and uh, you know it's being called his
Speaker 1: d platform ization across all of tech. Um and the
Speaker 1: reckoning for a Silicon valley, and the first Amendment is
Speaker 1: is really just beginning right, Um, may just got about
Speaker 1: thirty seconds. I mean, in general, I don't know if
Speaker 1: you guys have gone back the last few years, and
Speaker 1: I'm not trying to make this a President Trump thing,
Speaker 1: but in general, have we seen the level of toxic
Speaker 1: toxicity overall going up on social media? And my apologies,
Speaker 1: we do only have about twenty five seconds. Yes, it
Speaker 1: is definitely something that has been going up since the
Speaker 1: beginning of time. UM, and the you know, the valley
Speaker 1: has definitely definitely has a role to play and bringing
Speaker 1: that all down well really really interesting to get this
Speaker 1: from you, so thank you so much for joining us.
Speaker 1: Mayabe co founder and CEO of Writer. It is an
Speaker 1: AI and l N l P, which I now know
Speaker 1: is natural linguistic programming, so natural language process. Give it up.
Speaker 1: I'm giving up when it comes to acronyms. Thanks so
Speaker 1: much for listening to Bloomberg Business Week. Download the podcast
Speaker 1: on iTunes, SoundCloud, or at Bloomberg dot com, and be
Speaker 1: sure to check out our daily radio show at two
Speaker 1: pm Eastern on Bloomberg Radio. And be sure to watch
Speaker 1: us to on YouTube by searching Bloomberg Global News